Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters

A worldwide effort to counter the COVID-19 pandemic has resulted in hundreds of candidate vaccines moving through various stages of research and development, including several vaccines in phase 1, 2 and 3 clinical trials. A relatively small number of these vaccines have been evaluated in SARS-CoV-2...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:NPJ Vaccines
Autori principali: Brocato, Rebecca L., Kwilas, Steven A., Kim, Robert K., Zeng, Xiankun, Principe, Lucia M., Smith, Jeffrey M., Hooper, Jay W.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Brief Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835356/
https://ncbi.nlm.nih.gov/pubmed/33495468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-020-00279-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi